Altium Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-80,000
| Closed | -$3.37M | – | 80 |
|
|
2023
Q4 | $3.37M | Buy |
+80,000
| New | +$3.37M | 2.29% | 16 |
|
|
2023
Q3 | – | Sell |
-35,100
| Closed | -$666K | – | 70 |
|
|
2023
Q2 | $666K | Buy |
+35,100
| New | +$666K | 0.5% | 30 |
|
|
2021
Q3 | – | Sell |
-335,041
| Closed | -$3.54M | – | 140 |
|
|
2021
Q2 | $3.54M | Buy |
335,041
+105,419
| +46% | +$1.11M | 0.82% | 45 |
|
|
2021
Q1 | $3.68M | Buy |
229,622
+152,000
| +196% | +$2.44M | 1.02% | 38 |
|
|
2020
Q4 | $3.59M | Buy |
+77,622
| New | +$3.59M | 1.34% | 29 |
|